SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of August 31, 2026 in Insulet Corporation Lawsuit - PODD
Notice to Pension Funds, Asset Managers, and Fiduciaries Holding PODD: Institutional Portfolios Face Significant Exposure Following Two Omnipod Medical Device Corrections and Over $90 Per Share Decline from Pre-Disclosure Levels NEW YORK, Aug. 27, 2026 /PRNewswire/ -- Institutional...
Covered in this story
What has happened since
- Insulet Corporation is down 0.5% since this was published, 54 days ago.
Price move measured from the close nearest publication to the latest quote.
Analyst targets on Insulet Corporation
- Jefferies: $135 → $190 by Oct 2027 · Buy via Investing.com
- Raymond James: $139 → $180 by Aug 2027 · Outperform via Investing.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $PODD yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Insulet Corporation →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.